RNA antagonists targeting GLI2

Details for Australian Patent Application No. 2009272365 (hide)

Owner Santaris Pharma A/S Enzon Pharmaceuticals, Inc.

Inventors Hedtjarn, Maj

Agent Griffith Hack

Pub. Number AU-A-2009272365

PCT Pub. Number WO2010/007522

Priority 61/081,135 16.07.08 US; 08104754 15.07.08 EP

Filing date 15 July 2009

Wipo publication date 21 January 2010

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2010/007522 Priority application(s): WO2010/007522

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272369-Biomarkers for cardiodiabetes

2009272362-Clutch-brake assembly